Form 13F-HR Greenvale Capital LLP For: Mar 31
http://archive.fast-edgar.com/20220516/AVZ3Q22CZ22272C2222O22Z2HKC9ZT2I9242
Filed on: May 16, 2022
Form 13F-HR Camber Capital Managemen For: Mar 31
http://archive.fast-edgar.com/20220516/A2BZRG2CZ222SZZZ222Q2ZZE9WA4ZS22ZV42
Filed on: May 16, 2022
Form 13F-HR Unio Capital LLC For: Mar 31
http://archive.fast-edgar.com/20220516/A722JQ2CR2223ZZ2222S2Z4Z9RKHM2326242
Filed on: May 16, 2022
Form ABS-EE SANTANDER DRIVE AUTO For: Apr 30
http://archive.fast-edgar.com/20220516/AU2ZS222Z222G2K2222O2C425RNRZK22VT42
Filed on: May 16, 2022
Form NT 10-Q Generation Hemp, Inc. For: Mar 31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): ☐Form 10-K ☐Form 20-F ☐Form 11-K ☒ Form 10-Q ☐Form 10-D ☐ Form N-SAR ☐Form N-CSR
For Period Ended: March 31, 2022
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Orphazyme A/S For: May 16
-
Form 8-K Securetech Innovations, For: May 12
-
Form NT 10-Q Luduson G Inc. For: Mar 31
-
Form 13F-HR ACUTA CAPITAL PARTNERS, For: Mar 31
-
Form 8-K STRATUS PROPERTIES INC For: May 16
-
Form 10-Q MEWBOURNE ENERGY PARTNER For: Mar 31
-
Form 13F-HR D1 Capital Partners L.P. For: Mar 31
-
Form 497 SEPARATE ACCOUNT NY B
-
Form 10-Q Taysha Gene Therapies, For: Mar 31
-
Form S-1 ARTELO BIOSCIENCES, INC.
-
Form 8-K LogicBio Therapeutics, For: May 16
-
Form 8-A12B J.P. Morgan Exchange-Tra
-
Form 8-K Sunworks, Inc. For: May 16
-
Form D Future Capital Discovery
-
Form 497 SEPARATE ACCOUNT NY B
-
Form NT 10-Q Ever Harvest Internation For: Mar 31
-
Form 13F-HR SABBY MANAGEMENT, LLC For: Mar 31
-
Form ABS-EE SANTANDER DRIVE AUTO For: Apr 30
-
Form DEFA14A MIMEDX GROUP, INC.
-
Form 6-K Wix.com Ltd. For: May 16
-
Form 497 SEPARATE ACCOUNT NY B
-
Form 4 Nuvectis Pharma, Inc. For: May 12 Filed by: Hoberman Kenneth
-
Form 10-Q DATASEA INC. For: Mar 31
-
Form NT 10-Q Exceed World, Inc. For: Mar 31
-
Form SC 13D/A KE Holdings Inc. Filed by: Tencent Holdings Ltd
-
Form 4 Nuvectis Pharma, Inc. For: May 12 Filed by: Poradosu Enrique
-
Form 13F-NT Rokos Capital Management For: Mar 31
-
Form 4 Nuvectis Pharma, Inc. For: May 12 Filed by: Kaplan Matthew L.
-
Form 6-K Silence Therapeutics For: May 16
-
Form 497 SECURITY LIFE SEPARATE
-
Form 10-Q TINGO, INC. For: Mar 31
-
Form 6-K Silence Therapeutics For: May 16
-
Form 10-Q Forte Biosciences, Inc. For: Mar 31
-
Form 13F-HR 1060 Capital, LLC For: Mar 31
-
Form CERT i-80 Gold Corp.
-
Form 10-Q Iveda Solutions, Inc. For: Mar 31
-
Form 13F-HR Prime Movers Lab LLC For: Mar 31
-
Form 13F-HR Portsea Asset Management For: Mar 31
-
Form 10-D WFN CREDIT CO LLC For: Apr 30
-
Form 10-Q TELKONET INC For: Mar 31
-
Form 8-K BROADRIDGE FINANCIAL For: May 16
-
Form 8-K Vyant Bio, Inc. For: May 16
-
Form 4 IMMUNIC, INC. For: May 12 Filed by: Muehler Andreas
-
Form 13F-HR Stieven Capital Advisors For: Mar 31
-
Form 8-K BurgerFi International, For: May 16
-
Form 8-K Conformis Inc For: May 12
-
Form D 116 Street Ventures Fund
-
Form 13F-HR Tabor Asset Management, For: Mar 31
-
Form 13F-HR PARUS FINANCE (UK) Ltd For: Mar 31
-
Form 10-Q BioNexus Gene Lab Corp For: Mar 31